Advertisement

Blut

, Volume 43, Issue 6, pp 339–344 | Cite as

Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia

  • R. Storb
  • the Seattle Marrow Transplant Team
Leading Article

Keywords

Public Health Anemia Marrow Transplantation Aplastic Anemia Severe Aplastic Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Advisory Committee of the Bone Marrow Transplant Registry (1976) Bone marrow transplantation from donors with aplastic anemia. JAMA 236: 236Google Scholar
  2. 2.
    Bortin MM, Gale RP, Rimm AA for the Advisory Committee of the International Bone Marrow Transplant Registry (1981) Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. JAMA 245: 245Google Scholar
  3. 3.
    Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53: 504–4Google Scholar
  4. 4.
    Camitta BM, Storb R, Thomas ED (1981) Aplastic anemia: Pathogenesis, diagnosis, treatment and prognosis. N Engl J Med (in press)Google Scholar
  5. 5.
    Deeg HJ, Storb R, Prentice R, Fritz TE, Weiden PL, Sale GE, Graham TC, Thomas ED (1980) Increased cancer risk in canine radiation chimeras. Blood 55: 233–239Google Scholar
  6. 6.
    Deeg HJ, Storb R, Weiden PL, Graham TC, Atkinson K, Thomas ED (1981) Cyclosporin A: Effect on marrow engraftment and graft-versus-host disease in dogs. Transplant Proc 13: 402–404Google Scholar
  7. 7.
    Doney KC, Weiden PL, Storb R, Thomas ED (1981) Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol (in press)Google Scholar
  8. 8.
    Gluckman E, Devergie A, Dutreix A, Dutreix J, Boiron M, Bernard J (1980) Bone marrow grafting in aplastic anemia after conditioning with cyclophosphamide and total body irradiation with lung shielding. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, p 339Google Scholar
  9. 9.
    Gluckman E, Barrett J, Arcese W, Devergie A, Degoulet P (1981) Bone marrow transplantation in severe aplastic anemia — A survey of the European Group for Bone Marrow Transplantation. Br J Haematol (in press)Google Scholar
  10. 10.
    Kersey JH, Vallera DA, Soderling C, Warkentin P, Kim T, Levitt S, Nesbit ME, McGlave P, Woods WG, Krivit W, Coccia PF, Ramsay NKC (1980) Conditioning to reduce graft rejection following allogeneic marrow transplantation. In: Gale RP, Fox CF (eds) Biology of bone marrow transplantation. Academic Press Inc, New York, pp 29–36Google Scholar
  11. 11.
    Parkman R, Rappeport J, Camitta B, Levey RH, Nathan DG (1978) Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood 52: 1163–1169Google Scholar
  12. 12.
    Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HEM, Lawson D, McElwain TJ, Alexander P (1980) Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet I: 327–329Google Scholar
  13. 13.
    Rodt H, Kolb HJ, Netzel B, Haas RJ, Wilms K, Götze CB, Link H, Thierfelder S and the Munich Cooperative Group of BMT (1981) Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc 13: 257–261Google Scholar
  14. 14.
    Storb R, Epstein RB, Rudolph RH, Thomas ED (1970) The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J Immunol 105: 627–633Google Scholar
  15. 15.
    Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman PE (1974) Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180Google Scholar
  16. 16.
    Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Fernando LP, Giblett ER, Goodell BW, Johnson FL, Lerner KG, Neiman PE, Sanders JE (1976) Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 48: 817–841Google Scholar
  17. 17.
    Storb R, Prentice RL, Thomas ED (1977) Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296: 61–66Google Scholar
  18. 18.
    Storb R for the Seattle Marrow Transplant Team (1979) Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc 11: 196–198Google Scholar
  19. 19.
    Storb R, Weiden PL, Deeg HJ, Graham TC, Atkinson K, Slichter SJ, Thomas ED (1979) Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: Antigens involved are expressed on leukocytes and skin epithelial cells but non on platelets and red blood cells. Blood 54: 477–484Google Scholar
  20. 20.
    Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in thirty ≫untransfused patients with severe aplastic anemia.≪ Ann Intern Med 92: 30–36Google Scholar
  21. 21.
    Storb R, Doney KC, Thomas ED, Appelbaum FR, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan KM, Weiden PL, Witherspoon RP (1981) Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood (in press)Google Scholar
  22. 22.
    Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonal GB, Schubert MM, Atkinson K, Thomas ED (1981) Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57: 267–276Google Scholar
  23. 23.
    Thomas ED, Buckner CD, Storb R, Neiman PE, Fefer A, Clift RA, Slichter SJ, Funk DD, Bryant JI, Lerner KG (1972) Aplastic anemia treated by marrow transplantation. Lancet I: 284–289Google Scholar
  24. 24.
    Tutschka PJ, Beschorner WE, Allison AC, Burns WH, Santos GW (1979) Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature 280: 148–151Google Scholar
  25. 25.
    UCLA Bone Marrow Transplant Team (1981) Prevention of graft rejection following bone marrow transplantation. Blood 57: 9–12Google Scholar
  26. 26.
    Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson K, Thomas ED (1981) Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58: 360–368Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • R. Storb
    • 1
  • the Seattle Marrow Transplant Team
    • 1
  1. 1.Division of OncologyFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations